Protagonist Therapeutics
Earnings Surprise
Analysts estimated PTGX earnings of $-0.50 per share this quarter (Q4). PTGX's actual earnings were $-0.69 per share.
PTGX EPS surprise of -38.47%Analysts estimated PTGX earnings of $-0.59 per share this quarter (Q2). PTGX's actual earnings were $-0.55 per share.
PTGX EPS surprise of 6.78%Analysts estimated PTGX earnings of $-0.24 per share this quarter (Q1). PTGX's actual earnings were $-0.19 per share.
PTGX EPS surprise of 19.39%Analysts estimated PTGX earnings of $0.33 per share this quarter (Q4). PTGX's actual earnings were $1.98 per share.
PTGX EPS surprise of 504.58%Analysts estimated PTGX earnings of $-0.62 per share this quarter (Q3). PTGX's actual earnings were $-0.54 per share.
PTGX EPS surprise of 12.86%Analysts estimated PTGX earnings of $-0.61 per share this quarter (Q2). PTGX's actual earnings were $-0.50 per share.
PTGX EPS surprise of 18.53%Analysts estimated PTGX earnings of $1.22 per share this quarter (Q1). PTGX's actual earnings were $3.26 per share.
PTGX EPS surprise of 167.72%Analysts estimated PTGX earnings of $-0.03 per share this quarter (Q4). PTGX's actual earnings were $0.44 per share.
PTGX EPS surprise of -1397.94%Analysts estimated PTGX earnings of $-0.71 per share this quarter (Q3). PTGX's actual earnings were $-0.58 per share.
PTGX EPS surprise of -18.04%